'Crafted at Home, NexCar19 takes India to Next level in Cancer Care'

Kudos to Dr Purwar & team for their efforts,perseverance leading to #MadeInIndia #NexCar19
CAR-T cell Therapy in India

:Details by Soujanya Paddikal

#Cancer #Cancer Research #cure #Medicine #Science

#UPSC

'CAR-T cell therapy would be priced between Rs 30 lakh and Rs 40 lakh per patient, significantly cheaper than existing treatments, which cost 3-4 crore (INR) per patient,' says Gaurav Narula MD from Tata Memorial Hospital

Sakal Bhatt IIT Bombay

Watch full🔗youtu.be/lkxJojfpWUE?si…

President Droupadi Murmu launched India’s first home-grown gene therapy for cancer at IIT Bombay. The President said that as CAR-T cell therapy is accessible and affordable it provides a new hope for the whole of humankind. This is a praiseworthy example of academia-industry…

What is new about the therapy being launched today, as I understand it, is that it costs 90 percent less than what is available elsewhere. I am told that this is the world’s most affordable CAR-T cell therapy. Moreover, it is also an example of the ‘Make in India’ initiative; a…

A very proud moment for India and our CAR team….honorable president is addressing India’s first CAR T cell therapy to the nation…..
Rahul Purwar Gaurav Narula MD Hasmukh Jain Atharva Karulkar

Checkout the NexCAR19 development story published in Nature.
Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost
ImmunoACT Rahul Purwar Hasmukh Jain Gaurav Narula MD Nirali Shah NCI CCR Pediatric Oncology Branch

nature.com/articles/d4158…

Thanks for our story in detail!
When none believed, our institutions Tata Memorial Hospital IIT Bombay did!🙏
“I need a CAR, you need a Driver...” Off the cuff remark 😀😂 Never thought it’d make print some day eh Rahul Purwar
Hasmukh Jain Alka Dwivedi ImmunoACT CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC Albeena Nisar

Please checkout our excellent article on NCI’s role in developing first indigenous NexCAR19. NCI CCR Pediatric Oncology Branch Nirali Shah Rahul Purwar Gaurav Narula MD ImmunoACT

cancer.gov/news-events/ca…

Happy to share that I presented my NCI CCR Pediatric Oncology Branch work “off-the-shelf gamma delta CAR T cell therapy for AML” in 3rd SACT in Mumbai.

Oral Poster Presentations at #SACTEVENT2024 .

Gaurav Narula MD Albeena Nisar
ACTREC-TMC Tata Memorial Hospital CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC
SIOP-Africa SIOP Asia ISCT Early Stage Professionals Committee Department of Biotechnology
DBT-BIRAC

Congratulations Atharva Karulkar presenting ImmunoACT cost effectiveness of indigenous #CARTRx collaboration Tata Memorial Hospital IIT Bombay now #NexCAR19
Way to go 👍🏻👍🏻Rahul Purwar Hasmukh Jain Alka Dwivedi CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC #ASH23

Alka Dwivedi It is your hard work in discovery and Atharva Karulkar taking ahead the translational and clinical work! Proud of Both of you!

Thanks to Dr Hasmukh Jain Hasmukh Jain for working extremely hard in concluding the trial successfully that led to approvals of India’s first CART!

Huge 🙏 to Dr Narula Gaurav Narula MD Tata Memorial Hospital and Atharva Karulkar Alka Dwivedi IIT Bombay; wonderful collaboration! Jayashree Thorat

This is amazing ….. now wait is over for cancer patients😊… First CAR T will be available in the market soon….✌️

Groundbreaking! To ensure CART access to everyone who will benefit from these therapies- we are building a new facility in Mumbai! Once ready, it will serve many patients.

Chandrayaan-3 Mission:
'India🇮🇳,
I reached my destination
and you too!'
: Chandrayaan-3

Chandrayaan-3 has successfully
soft-landed on the moon 🌖!.

Congratulations, India🇮🇳!

#Chandrayaan_3
#Ch3

New #CCRadvance paper out now by Dr. Sara Silbert & Dr. Nirali Shah and collaborators: 'A Comprehensive Analysis of Adverse Events in the First 30 Days of Phase 1 Pediatric CAR T-Cell Trials' #Immunotherapy #CARTcells
Read here: bit.ly/3YfuNvE

Many congratulations and best wishes to Tata Memorial Hospital and ImmunoACT for this wonderful collaboration. Feeling overwhelmed to see this in reality, I still remember our very first discussion when CART in India seemed like a science fiction.

It was indeed an honour to meet you all! Thanks to Shalini Jatia for an excellent overview and engaging discussion.

Laurus Labs Ups Stake In ImmunoAct | Trading Hour | CNBC TV18 youtu.be/fQZY_tdFePs via YouTube